Last reviewed · How we verify

NCT02872922

Effects of Low Intensity Therapeutic Ultrasound on Endothelial Function

Completed NA Last updated 21 September 2017
What this trial tests

NA trial testing Low intensity therapeutic ultrasound in Diabetes Mellitus, Type 2 in 22 participants. Completed in 20 September 2017.

Timeline
10 December 2016
Primary endpoint
20 September 2017
20 September 2017

Quick facts

Lead sponsorUniversidade Federal de Santa Maria
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment22
Start date10 December 2016
Primary completion20 September 2017
Estimated completion20 September 2017
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal de Santa Maria — full company profile →

Who can join

Adults 25 to 65, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endothelium is a cell layer that interposes blood and smooth muscle of vessels. This biological sensor reacts to physical and chemical stimuli by synthesis and/or liberation of regulatory substances like nitric oxide (NO), which acts on vascular tone, growth of muscle cells and platelet aggregation and leukocyte. Clinically, endothelial function measured by technique flow-mediated dilation (FMD) is a strong predictor of cardiovascular events and all-cause mortality. Previo study demonstrated that continuous and pulsed therapeutic 1-MHz ultrasound waveforms improved endothelial function in health volunteers and this vasodilation persisted for 20 min, which provided them with anti-inflammatory vascular effects. In subjects with type 2 diabetes (DM2) the chronical hyperglycemia and dyslipidemia reduce NO bioavailability causing endothelial dysfunction. Low intensity therapeutic ultrasound is an electrotherapeutic instrument employed in musculoskeletal injuries that promotes endothelium-dependent vasodilation, and its mechanism of action has not been studied on DM2. The aim of our study is evaluate endothelial function of patients with DM2 after different waveforms (placebo, continuous and pulsed) of therapeutic ultrasound. Therapeutic ultrasound is a electrotherapeutic instrument that can changes arterial endothelial function of subjects with DM2 because of NO bioavailability increasing, which implies anti-inflammatory and vasodilatory beneficial alterations for diabetic patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Ultrasound Therapy: Experiences and Perspectives for Regenerative Medicine.
    de Lucas B, Pérez LM, Bernal A, Gálvez BG. · · 2020 · cited 38× · PMID 32957737 · DOI 10.3390/genes11091086

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

Other Universidade Federal de Santa Maria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02872922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing